TACSTD2 and neoplasm: Fluorescence imaging further confirmed rapid and preferential accumulation of hRS7-PTX within TROP2-rich tumor tissues.<h4>Discussion</h4>These findings establish hRS7-PTX as an effective, solvent-free strategy for targeted PTX delivery that expands the therapeutic index of this widely used drug.